Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OCGN · against 1,216 other Healthcare companies
Ranked #603 of 1,217 · scores higher than 50% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 50–59, including OCGN · Click a bar to see the companies
A mix: stronger 3-year revenue growth, but weaker earnings per share growth and revenue growth than most Healthcare peers.
| Metric | OCGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -3.6% | 6.1% | 23% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 26.3% | 5.8% | 86% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 603 | 11.6B USD | 50 | 57 | |
| 603 | 43.2B USD | 50 | 45 | |
| 603 | 133.4B BRL (≈$24.0B) | 50 | 49 | |
| 603 | 21.1B ZAR (≈$1.2B) | 50 | 60 | |
| 603 | 253M USD | 50 | 15 | |
| 603 | 3.0B USD | 50 | 39 | |
| 603 | 1.6B USD | 50 | 48 | |
| 616 | 11.6B HKD (≈$1.5B) | 49 | 36 | |
| 616 | 406.2B KRW (≈$292M) | 49 | 51 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score